Joanna Laurson-Doube

Cell biologist and European. Focused on global health. Views are my own.

[MSJ @MSJ_Research]

📢January issue is now available ▶️ https://t.co/R9gufw3TDl

...and the cover goes to @jlaurson @Doxoki @MSIntFederation with their roadmap of implementation for #MultipleSclerosis disease-modifying therapies entering the #WHO Essential Medicines List ▶️ https://t.co/yCy8Rzg8mr

[M&M_MD_PhD @monicacmarta]

#MSATL2023 ⁦@MSIntFederation⁩ @who #eml #DMT

[Deanna Saylor @DeannaSaylor1]

On this #WorldMSDay, happy to see our efforts to improve care for people with #MultipleSclerosis in #Africa moving forward. Thanks to @Doxoki for hosting a great meeting in #Kenya to launch #AFRICTRIMS! Also happy to have a new friend, @dryaredzewde!

[Cochrane @cochranecollab]

Everyone should have equal & affordable access to #MultipleSclerosis treatments.
We have endorsed @MSIntFederation & WHO Collaborating Centre Bologna’s application to add #MS treatments to the @WHO’s Essential Medicines List. #MSTreatmentForAll
https://t.co/lOFaDY5ivg

[MS Int'l Federation @MSIntFederation]

Today at the Indian Committee of Treatment and Research in Multiple Sclerosis (@ictrimsdelhi), Dr Lekha Pandit presented on the @WHO decision to add MS treatments to their Essential Medicines List. Read more about the decision here. 👉https://t.co/P12OA9NQnv

[MS Int'l Federation @MSIntFederation]

Last week at the Association of South East Asian Nations Neurological Association, Dr Viswanathan, a Neurologist from Malaysia, shared advocacy tools for improved #AccessToMedicines for MS, including information on the MS treatments listed on the @WHO's EML.

[MS Int'l Federation @MSIntFederation]

The @WHO has recently included MS treatments on its Essential Medicines List (EML). This comment, made by EML Expert Committee regarding our EML application, is a testament the exceptional quality and rigour of the application, made possible by the global collaboration. 🌍

[Multiple Sclerosis News Today @MSNewsToday]

For the first time in its history, MS therapies are now included on the World Health Organization’s Model Lists of Essential Medicines. https://t.co/lAQCJ1eas0

#multiplesclerosis #msnews #msawareness #mscommunity

[MS Canada @MSCanOfficial]

We are a proud member of the Multiple Sclerosis International Federation (MSIF) and today, we celebrate the addition of #MSTreatments to WHO’s Essential Medicines List, which will promote and support #PositiveChange for access to MS treatments worldwide: https://t.co/HOyfhcDVYr

[World Health Organization (WHO) @WHO]

Three medicines that can delay or slow multiple sclerosis progression - cladribine, glatiramer acetate and rituximab - are added to the WHO Essential Medicines List, filling an important gap given the large global burden of the chronic, debilitating disease of the nervous system.

Multiple sclerosis affecting approximately 2.8 million people worldwide https://t.co/M8sxzsIG0L

[Joanna Laurson-Doube @jlaurson]

@MSIntFederation @DeannaSaylor1

[Sakhi Bhansali @DrSakhii]

I still remember seeing young patients with demyelinating disorders decompensate due to lack of inexpensive disease modifying therapy in med school. Big step in the direction but a long way to go... #neurotwitter #MedTwitter #globalneurology

[Reuters @Reuters]

Obesity drugs don't make WHO's essential list, but Ebola, MS drugs added https://t.co/9d2jYeeORp

[Deanna Saylor @DeannaSaylor1]

Such an important milestone for the global #MS community! Thanks to @MSIntFederation for leading the way on this important effort! @ECTRIMS @ACTRIMS @lactrims_org @PACTRIMS_admin

[World Neurology Foundation @WnfoNeurology]

Congratulations to the @MSIntFederation! 🙌 The future is bright for patients with #MS 🧠

[MS Int'l Federation @MSIntFederation]

🌍Fantastic news! Today the World Health Organization (WHO) added three disease modifying-therapies (DMTs) 💊for multiple sclerosis (MS) to its Essential Medicines List! It is a significant moment in the history of MS.
Learn more here: https://t.co/L7Jheo55VF

#MSTreatmentForAll

[European MS Platform @eumsplatform]

The decision of the @WHO to include #MS treatments on the Essential Medicines List marks an important milestone for the global MS community and our work to facilitate access to MS treatments all over the globe. Learn more👉 https://t.co/JssUvQaogb

[Deanna Saylor @DeannaSaylor1]

Today is a momentous day for people with #MS globally. Proud to have contributed to this work and thankful to @WHO for recognizing #access to treatment is essential for everyone. Thanks to @MSIntFederation for leading this work and so many others!

[James Packard Love, jamielove.bsky.social @jamie_love]

WHO rejects application to include risdiplam as a treatment for SMA on its model list of essential medicines.

https://t.co/1NRwiuM4cF

[Mar Tintore @MarTintore]

Best news! #MSTreatmentsForAll! @ECTRIMS @MSIF @cemcat_em